Announcements
Sidley Represents Nourish in US$100 Million Series C Financing
May 19, 2026
Sidley represented Nourish, the largest dietitian-led metabolic health clinic in the United States, in its US$100 million Series C financing. The round was led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners.
The financing brings Nourish’s total funding to US$215 million. Nourish plans to use the proceeds to grow its clinical network, accelerate investment in AI agents for patients and providers, expand its metabolic clinic care model, and deepen partnerships with health plans, employers, and health systems.
The Sidley team was led by S. Scott Parel and Nick DeAngelis (M&A and Private Equity), Idan Netser (Emerging Companies and Venture Capital) and Jon S. Zucker (Healthcare) and included Lauren G. Grau (Technology and Life Sciences Transactions); Tara M. Lancaster (Tax); Margaret H. Allen (Labor, Employment and Immigration); and Lauren Kitces and Sheri Porath Rockwell (Privacy and Cybersecurity).
The financing brings Nourish’s total funding to US$215 million. Nourish plans to use the proceeds to grow its clinical network, accelerate investment in AI agents for patients and providers, expand its metabolic clinic care model, and deepen partnerships with health plans, employers, and health systems.
The Sidley team was led by S. Scott Parel and Nick DeAngelis (M&A and Private Equity), Idan Netser (Emerging Companies and Venture Capital) and Jon S. Zucker (Healthcare) and included Lauren G. Grau (Technology and Life Sciences Transactions); Tara M. Lancaster (Tax); Margaret H. Allen (Labor, Employment and Immigration); and Lauren Kitces and Sheri Porath Rockwell (Privacy and Cybersecurity).
連絡先
得意分野
Suggested News & Insights
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private PlacementJuly 17, 2026Sidley Finishes H1 2026 Among Top Three US$1B+ Dealmakers in TexasJuly 16, 2026European Commission Signals Targeted Procedural Simplification of the Foreign Subsidies Regulation – Without Weakening EnforcementJuly 16, 2026Inspection Rights, Internal Affairs, and Personal Jurisdiction: Orchid Global’s Procedural LessonJuly 15, 2026Sidley Advises EMZ Partners on Its Significant Minority Investment in Steinbach & VollmannJuly 13, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory





